Active, Not Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
NCT05524883
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- UCLA University California of Los Angeles Los Angeles, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Rare Disease Research, LLC Atlanta, Georgia, United States